CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
Market Analysis and Insights: Global CRISPR/Cas9 Market
The global CRISPR/Cas9 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRISPR/Cas9 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRISPR/Cas9 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRISPR/Cas9 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRISPR/Cas9 market.
CRISPR/Cas9 Breakdown Data by Type
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
CRISPR/Cas9 Breakdown Data by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Based on regional and country-level analysis, the CRISPR/Cas9 market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global CRISPR/Cas9 market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Caribou Biosciences
Integrated DNA Technologies (IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Market Analysis and Insights: Global CRISPR/Cas9 Market
The global CRISPR/Cas9 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRISPR/Cas9 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRISPR/Cas9 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRISPR/Cas9 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRISPR/Cas9 market.
CRISPR/Cas9 Breakdown Data by Type
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
CRISPR/Cas9 Breakdown Data by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Based on regional and country-level analysis, the CRISPR/Cas9 market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global CRISPR/Cas9 market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Caribou Biosciences
Integrated DNA Technologies (IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR/Cas9 Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR/Cas9 Market Share by Application: 2020 VS 2026
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CRISPR/Cas9 Market Perspective (2015-2026)
2.2 Global CRISPR/Cas9 Growth Trends by Regions
2.2.1 CRISPR/Cas9 Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CRISPR/Cas9 Historic Market Share by Regions (2015-2020)
2.2.3 CRISPR/Cas9 Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR/Cas9 Players by Market Size
3.1.1 Global Top CRISPR/Cas9 Players by Revenue (2015-2020)
3.1.2 Global CRISPR/Cas9 Revenue Market Share by Players (2015-2020)
3.2 Global CRISPR/Cas9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRISPR/Cas9 Revenue
3.4 Global CRISPR/Cas9 Market Concentration Ratio
3.4.1 Global CRISPR/Cas9 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR/Cas9 Revenue in 2019
3.5 Key Players CRISPR/Cas9 Area Served
3.6 Key Players CRISPR/Cas9 Product Solution and Service
3.7 Date of Enter into CRISPR/Cas9 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR/Cas9 Breakdown Data by Type (2015-2026)
4.1 Global CRISPR/Cas9 Historic Market Size by Type (2015-2020)
4.2 Global CRISPR/Cas9 Forecasted Market Size by Type (2021-2026)
5 CRISPR/Cas9 Breakdown Data by Application (2015-2026)
5.1 Global CRISPR/Cas9 Historic Market Size by Application (2015-2020)
5.2 Global CRISPR/Cas9 Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CRISPR/Cas9 Market Size (2015-2026)
6.2 North America CRISPR/Cas9 Market Size by Type (2015-2020)
6.3 North America CRISPR/Cas9 Market Size by Application (2015-2020)
6.4 North America CRISPR/Cas9 Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe CRISPR/Cas9 Market Size (2015-2026)
7.2 Europe CRISPR/Cas9 Market Size by Type (2015-2020)
7.3 Europe CRISPR/Cas9 Market Size by Application (2015-2020)
7.4 Europe CRISPR/Cas9 Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China CRISPR/Cas9 Market Size (2015-2026)
8.2 China CRISPR/Cas9 Market Size by Type (2015-2020)
8.3 China CRISPR/Cas9 Market Size by Application (2015-2020)
8.4 China CRISPR/Cas9 Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan CRISPR/Cas9 Market Size (2015-2026)
9.2 Japan CRISPR/Cas9 Market Size by Type (2015-2020)
9.3 Japan CRISPR/Cas9 Market Size by Application (2015-2020)
9.4 Japan CRISPR/Cas9 Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia CRISPR/Cas9 Market Size (2015-2026)
10.2 Southeast Asia CRISPR/Cas9 Market Size by Type (2015-2020)
10.3 Southeast Asia CRISPR/Cas9 Market Size by Application (2015-2020)
10.4 Southeast Asia CRISPR/Cas9 Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Details
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences CRISPR/Cas9 Introduction
11.1.4 Caribou Biosciences Revenue in CRISPR/Cas9 Business (2015-2020))
11.1.5 Caribou Biosciences Recent Development
11.2 Integrated DNA Technologies (IDT)
11.2.1 Integrated DNA Technologies (IDT) Company Details
11.2.2 Integrated DNA Technologies (IDT) Business Overview
11.2.3 Integrated DNA Technologies (IDT) CRISPR/Cas9 Introduction
11.2.4 Integrated DNA Technologies (IDT) Revenue in CRISPR/Cas9 Business (2015-2020)
11.2.5 Integrated DNA Technologies (IDT) Recent Development
11.3 CRISPR Therapeutics
11.3.1 CRISPR Therapeutics Company Details
11.3.2 CRISPR Therapeutics Business Overview
11.3.3 CRISPR Therapeutics CRISPR/Cas9 Introduction
11.3.4 CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2015-2020)
11.3.5 CRISPR Therapeutics Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck CRISPR/Cas9 Introduction
11.4.4 Merck Revenue in CRISPR/Cas9 Business (2015-2020)
11.4.5 Merck Recent Development
11.5 Mirus Bio
11.5.1 Mirus Bio Company Details
11.5.2 Mirus Bio Business Overview
11.5.3 Mirus Bio CRISPR/Cas9 Introduction
11.5.4 Mirus Bio Revenue in CRISPR/Cas9 Business (2015-2020)
11.5.5 Mirus Bio Recent Development
11.6 Editas Medicine
11.6.1 Editas Medicine Company Details
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine CRISPR/Cas9 Introduction
11.6.4 Editas Medicine Revenue in CRISPR/Cas9 Business (2015-2020)
11.6.5 Editas Medicine Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio CRISPR/Cas9 Introduction
11.7.4 Takara Bio Revenue in CRISPR/Cas9 Business (2015-2020)
11.7.5 Takara Bio Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific CRISPR/Cas9 Introduction
11.8.4 Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2015-2020)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Details
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group CRISPR/Cas9 Introduction
11.9.4 Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2015-2020)
11.9.5 Horizon Discovery Group Recent Development
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Details
11.10.2 Intellia Therapeutics Business Overview
11.10.3 Intellia Therapeutics CRISPR/Cas9 Introduction
11.10.4 Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2015-2020)
11.10.5 Intellia Therapeutics Recent Development
11.11 Agilent Technologies
10.11.1 Agilent Technologies Company Details
10.11.2 Agilent Technologies Business Overview
10.11.3 Agilent Technologies CRISPR/Cas9 Introduction
10.11.4 Agilent Technologies Revenue in CRISPR/Cas9 Business (2015-2020)
10.11.5 Agilent Technologies Recent Development
11.12 Cellecta
10.12.1 Cellecta Company Details
10.12.2 Cellecta Business Overview
10.12.3 Cellecta CRISPR/Cas9 Introduction
10.12.4 Cellecta Revenue in CRISPR/Cas9 Business (2015-2020)
10.12.5 Cellecta Recent Development
11.13 GenScript
10.13.1 GenScript Company Details
10.13.2 GenScript Business Overview
10.13.3 GenScript CRISPR/Cas9 Introduction
10.13.4 GenScript Revenue in CRISPR/Cas9 Business (2015-2020)
10.13.5 GenScript Recent Development
11.14 GeneCopoeia
10.14.1 GeneCopoeia Company Details
10.14.2 GeneCopoeia Business Overview
10.14.3 GeneCopoeia CRISPR/Cas9 Introduction
10.14.4 GeneCopoeia Revenue in CRISPR/Cas9 Business (2015-2020)
10.14.5 GeneCopoeia Recent Development
11.15 Synthego
10.15.1 Synthego Company Details
10.15.2 Synthego Business Overview
10.15.3 Synthego CRISPR/Cas9 Introduction
10.15.4 Synthego Revenue in CRISPR/Cas9 Business (2015-2020)
10.15.5 Synthego Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR/Cas9 Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR/Cas9 Market Share by Application: 2020 VS 2026
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CRISPR/Cas9 Market Perspective (2015-2026)
2.2 Global CRISPR/Cas9 Growth Trends by Regions
2.2.1 CRISPR/Cas9 Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CRISPR/Cas9 Historic Market Share by Regions (2015-2020)
2.2.3 CRISPR/Cas9 Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR/Cas9 Players by Market Size
3.1.1 Global Top CRISPR/Cas9 Players by Revenue (2015-2020)
3.1.2 Global CRISPR/Cas9 Revenue Market Share by Players (2015-2020)
3.2 Global CRISPR/Cas9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRISPR/Cas9 Revenue
3.4 Global CRISPR/Cas9 Market Concentration Ratio
3.4.1 Global CRISPR/Cas9 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR/Cas9 Revenue in 2019
3.5 Key Players CRISPR/Cas9 Area Served
3.6 Key Players CRISPR/Cas9 Product Solution and Service
3.7 Date of Enter into CRISPR/Cas9 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR/Cas9 Breakdown Data by Type (2015-2026)
4.1 Global CRISPR/Cas9 Historic Market Size by Type (2015-2020)
4.2 Global CRISPR/Cas9 Forecasted Market Size by Type (2021-2026)
5 CRISPR/Cas9 Breakdown Data by Application (2015-2026)
5.1 Global CRISPR/Cas9 Historic Market Size by Application (2015-2020)
5.2 Global CRISPR/Cas9 Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CRISPR/Cas9 Market Size (2015-2026)
6.2 North America CRISPR/Cas9 Market Size by Type (2015-2020)
6.3 North America CRISPR/Cas9 Market Size by Application (2015-2020)
6.4 North America CRISPR/Cas9 Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe CRISPR/Cas9 Market Size (2015-2026)
7.2 Europe CRISPR/Cas9 Market Size by Type (2015-2020)
7.3 Europe CRISPR/Cas9 Market Size by Application (2015-2020)
7.4 Europe CRISPR/Cas9 Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China CRISPR/Cas9 Market Size (2015-2026)
8.2 China CRISPR/Cas9 Market Size by Type (2015-2020)
8.3 China CRISPR/Cas9 Market Size by Application (2015-2020)
8.4 China CRISPR/Cas9 Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan CRISPR/Cas9 Market Size (2015-2026)
9.2 Japan CRISPR/Cas9 Market Size by Type (2015-2020)
9.3 Japan CRISPR/Cas9 Market Size by Application (2015-2020)
9.4 Japan CRISPR/Cas9 Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia CRISPR/Cas9 Market Size (2015-2026)
10.2 Southeast Asia CRISPR/Cas9 Market Size by Type (2015-2020)
10.3 Southeast Asia CRISPR/Cas9 Market Size by Application (2015-2020)
10.4 Southeast Asia CRISPR/Cas9 Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Details
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences CRISPR/Cas9 Introduction
11.1.4 Caribou Biosciences Revenue in CRISPR/Cas9 Business (2015-2020))
11.1.5 Caribou Biosciences Recent Development
11.2 Integrated DNA Technologies (IDT)
11.2.1 Integrated DNA Technologies (IDT) Company Details
11.2.2 Integrated DNA Technologies (IDT) Business Overview
11.2.3 Integrated DNA Technologies (IDT) CRISPR/Cas9 Introduction
11.2.4 Integrated DNA Technologies (IDT) Revenue in CRISPR/Cas9 Business (2015-2020)
11.2.5 Integrated DNA Technologies (IDT) Recent Development
11.3 CRISPR Therapeutics
11.3.1 CRISPR Therapeutics Company Details
11.3.2 CRISPR Therapeutics Business Overview
11.3.3 CRISPR Therapeutics CRISPR/Cas9 Introduction
11.3.4 CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2015-2020)
11.3.5 CRISPR Therapeutics Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck CRISPR/Cas9 Introduction
11.4.4 Merck Revenue in CRISPR/Cas9 Business (2015-2020)
11.4.5 Merck Recent Development
11.5 Mirus Bio
11.5.1 Mirus Bio Company Details
11.5.2 Mirus Bio Business Overview
11.5.3 Mirus Bio CRISPR/Cas9 Introduction
11.5.4 Mirus Bio Revenue in CRISPR/Cas9 Business (2015-2020)
11.5.5 Mirus Bio Recent Development
11.6 Editas Medicine
11.6.1 Editas Medicine Company Details
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine CRISPR/Cas9 Introduction
11.6.4 Editas Medicine Revenue in CRISPR/Cas9 Business (2015-2020)
11.6.5 Editas Medicine Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio CRISPR/Cas9 Introduction
11.7.4 Takara Bio Revenue in CRISPR/Cas9 Business (2015-2020)
11.7.5 Takara Bio Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific CRISPR/Cas9 Introduction
11.8.4 Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2015-2020)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Details
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group CRISPR/Cas9 Introduction
11.9.4 Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2015-2020)
11.9.5 Horizon Discovery Group Recent Development
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Details
11.10.2 Intellia Therapeutics Business Overview
11.10.3 Intellia Therapeutics CRISPR/Cas9 Introduction
11.10.4 Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2015-2020)
11.10.5 Intellia Therapeutics Recent Development
11.11 Agilent Technologies
10.11.1 Agilent Technologies Company Details
10.11.2 Agilent Technologies Business Overview
10.11.3 Agilent Technologies CRISPR/Cas9 Introduction
10.11.4 Agilent Technologies Revenue in CRISPR/Cas9 Business (2015-2020)
10.11.5 Agilent Technologies Recent Development
11.12 Cellecta
10.12.1 Cellecta Company Details
10.12.2 Cellecta Business Overview
10.12.3 Cellecta CRISPR/Cas9 Introduction
10.12.4 Cellecta Revenue in CRISPR/Cas9 Business (2015-2020)
10.12.5 Cellecta Recent Development
11.13 GenScript
10.13.1 GenScript Company Details
10.13.2 GenScript Business Overview
10.13.3 GenScript CRISPR/Cas9 Introduction
10.13.4 GenScript Revenue in CRISPR/Cas9 Business (2015-2020)
10.13.5 GenScript Recent Development
11.14 GeneCopoeia
10.14.1 GeneCopoeia Company Details
10.14.2 GeneCopoeia Business Overview
10.14.3 GeneCopoeia CRISPR/Cas9 Introduction
10.14.4 GeneCopoeia Revenue in CRISPR/Cas9 Business (2015-2020)
10.14.5 GeneCopoeia Recent Development
11.15 Synthego
10.15.1 Synthego Company Details
10.15.2 Synthego Business Overview
10.15.3 Synthego CRISPR/Cas9 Introduction
10.15.4 Synthego Revenue in CRISPR/Cas9 Business (2015-2020)
10.15.5 Synthego Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
